Showing results (651-660 of 789) with videos related to

Sort By:
Pageof 79
Scientific Reports|October 15, 2017
Pharmacological HIF-inhibition attenuates postoperative adhesion formationMoritz J Strowitzki, Alina S Ritter, Praveen Radhakrishnan, et al.
Archives of Gynecology and Obstetrics|September 3, 2017
Pathobiology of myomatosis uteri: the underlying knowledge to support our clinical practiceLuz Angela Torres-de la Roche, Sven Becker, Cristina Cezar, et al.
Geburtshilfe Und Frauenheilkunde|March 24, 2015
Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGGM W Beckmann, I Juhasz-Böss, D Denschlag, et al.
Breast Cancer Research and Treatment|July 3, 2020
Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancerVincent Walter, Chiara Fischer, Thomas M Deutsch, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Treatment Landscape and Prognosis After Treatment with Trastuzumab EmtansineElena Laakmann, Julius Emons, Florin-Andrei Taran, et al.
Breast Cancer Research and Treatment|November 21, 2022
Return of individual genomic research results within the PRAEGNANT multicenter registry studyHanna Huebner, Matthias Ruebner, Christian Kurbacher, et al.
Archives of Gynecology and Obstetrics|November 17, 2020
Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in GermanyDonata Grimm, Petra Voiss, Daniela Paepke, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|March 1, 2017
Decidualization is Impaired in Endometrial Stromal Cells from Uterine Rudiments in Mayer-Rokitansky-Küster-Hauser SyndromeSara Y Brucker, Simone Eisenbeis, Juliana König, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 18, 2016
Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implicationsStefan Stefanovic, Markus Wallwiener, Uros Karic, et al.
Pageof 79